ATIM-10. A PHASE I/II CLINICAL TRIAL OF AUTOLOGOUS CMV-SPECIFIC CYTOTOXIC T CELLS (CMV-TC) FOR GLIOBLASTOMA: DOSE ESCALATION AND CORRELATIVE RESULTS

BACKGROUND: Cytomegalovirus (CMV) antigens are present in > 90% of GBMs but not in normal brain. CMV-TC in GBM tumor tissue have their effector function suppressed. Highly functional CMV pp65 specific T cells can be expanded in vitro from peripheral blood (PB) of GBM patients. METHODS: Autologous...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Penas-Prado, Marta, Weathers, Shiao-Pei, Zhou, Shouhao, Kamiya-Matsuoka, Carlos, O’Brien, Barbara, Loghin, Monica, Harrison, Rebecca, Pei, Be Lian, Ictech, Sandra, Hunter, Kathy, Yung, W K Alfred, de Groot, John, Shpall, Elizabeth J, Heimberger, Amy, Rezvani, Katy
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216121/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados